Interleukin 10 supplement to reduce episodes of recurrent aphthous stomatitis

doi:10.5662/wjm.v15.i3.99176

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

HTML

Figures (1-1)

Sum=3

Sep 20, 2025 (publication date) through Mar 6, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Methodology

ISSN

2222-0682

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Methodol. Sep 20, 2025; 15(3): 99176
Published online Sep 20, 2025. doi: 10.5662/wjm.v15.i3.99176

Interleukin 10 supplement to reduce episodes of recurrent aphthous stomatitis

Cinzia Casu, Angelo Michele Inchingolo, Germano Orrù

Cinzia Casu, Germano Orrù, Department of Surgical Science, Oral Biotechnology Laboratory, University of Cagliari, Cagliari 09124, Italy

Angelo Michele Inchingolo, Department of Interdisciplinary Medicine, School of Medicine, University of Bari “Aldo Moro”, Bari 70124, Italy

Co-corresponding authors: Cinzia Casu and Germano Orrù.

Author contributions: Casu C and Orrù G observed the patients, collected data, made maps, and consulted the literature, they contributed equally to this article, they are the co-corresponding authors of this manuscript; Casu C and Inchingolo AM wrote the manuscript; Inchingolo AM and Orrù G revised the manuscript and the literature citations; and all authors have read and approved the final manuscript.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Cinzia Casu, PhD, Department of Surgical Science, Oral Biotechnology Laboratory, University of Cagliari, Via ospedale 54, Cagliari 09124, Italy. ginzia.85@hotmail.it

Received: July 15, 2024
Revised: January 3, 2025
Accepted: February 8, 2025
Published online: September 20, 2025
Processing time: 233 Days and 9.8 Hours

Core Tip

Core Tip: Aphthous lesions and recurrent aphthous stomatitis are among the most common oral diseases and are often very painful. In some patients, the frequency of new onset is greater than once a month. The pathogenetic mechanism involves high levels of interleukin (IL)-1 and IL-6 and low levels of IL-10. Although several aids that are able to reduce healing times and pain have been proposed in the scientific literature, there is still no treatment that drastically reduces the frequency of lesion onset. Supplements based on IL-10, administered at low doses for prolonged periods, referred to as low-dose medicine, could be effective in reducing relapses.